In a study by Li et al. 47, they studied a CRC-specific aptamer that specifically targeted ephrin type-A receptor 2 (EphA2), a protein involved in cell migration and invasion, in EphA2-expressing CRC cell line, LoVo cells. This evidence concerns the gene EPHA2 and colorectal carcinoma.